Rivaroxaban NDC 14445-184

NDC codes

FDA NDC Directory

Product NDC (as listed)14445-184Labeler and product segments. Claims need a package NDC.

Product NDC at billing width14445-0184Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
14445-184-00	14445018400	1000 TABLET, FILM COATED in 1 BOTTLE (14445-184-00)Marketed from Aug 11, 2025
14445-184-10	14445018410	10 BLISTER PACK in 1 CARTON (14445-184-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK (14445-184-02)Marketed from Aug 11, 2025
14445-184-30	14445018430	30 TABLET, FILM COATED in 1 BOTTLE (14445-184-30)Marketed from Aug 11, 2025
14445-184-90	14445018490	90 TABLET, FILM COATED in 1 BOTTLE (14445-184-90)Marketed from Aug 11, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rivaroxaban
Generic name (nonproprietary): rivaroxaban
Active ingredients: Rivaroxaban — 20 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Indoco Remedies Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218445
Marketing start: Aug 11, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Factor Xa Inhibitors (Mechanism)
Identifiers: Product ID 14445-184_b57414a3-eca8-4cda-b7eb-7c060d52a6b6SPL ID b57414a3-eca8-4cda-b7eb-7c060d52a6b6SPL set ID 9fee7136-c8fd-4bea-ab15-7a0e7292396dRxCUI 1114198, 1232082, 1232086, 2059015UNII 9NDF7JZ4M3UPC 0314445184301, 0314445147603, 0314445148303, 0314445183304
Pharmacologic class: Factor Xa Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N414445018400 followed by a unit qualifier and the quantity

Package 14445-0184-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 28, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Rivaroxaban tablet is a factor Xa inhibitor indicated: to reduce risk of stroke and systemic embolism in nonvalvular atrial fibrillation ( 1.1 ) for treatment of deep vein thrombosis (DVT) ( 1.2 ) for treatment of pulmonary embolism (PE) ( 1.3 ) for reduction in the risk of recurrence of DVT or PE ( 1.4 ) for the prophylaxis of DVT, which may lead to PE in patients undergoing knee or hip replacement surgery ( 1.5 ) for prophylaxis of venous thromboembolism (VTE) in acutely ill medical patients ( 1.6 ) to reduce the risk of major cardiovascular events in patients with coronary artery disease (CAD) ( 1.7 ) to reduce the risk of major thrombotic vascular events in patients with peripheral arter…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 218445

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218445
Product	Strength	Form · route	Labeler	Product NDC
Rivaroxaban	Rivaroxaban 2.5 mg/1	Tablet, Film coatedOral	Indoco Remedies Limited	14445-147
Rivaroxaban	Rivaroxaban 10 mg/1	Tablet, Film coatedOral	Indoco Remedies Limited	14445-148
Rivaroxaban	Rivaroxaban 15 mg/1	Tablet, Film coatedOral	Indoco Remedies Limited	14445-183
rivaroxaban	Rivaroxaban 2.5 mg/1	TabletOral	Florida Pharmaceutical Products, LLC	71921-405